Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Damla Yürük
There are two groups in the trial. One group will receive transcutaneous pulsed radiofrequency treatment for a total of 3 weekly sessions. The other group will receive 1x 5 mg flunarizine active ingredient. Both groups will consist of 30 patients. All patients will be followed from the start of treatment and will be assessed at month 1 and month 3 using the paediatric migraine disability index, headache diaries and visual pain scale.
Age
7–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with migraine according to ICHD-3 Migraine criteria